<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="1820">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on December 16, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05137470</url>
  </required_header>
  <id_info>
    <org_study_id>YYYXYJ-2021-275</org_study_id>
    <nct_id>NCT05137470</nct_id>
  </id_info>
  <brief_title>Emotion and Cognitive Function and Brain Imaging Change in HD Patients</brief_title>
  <official_title>Study on the Changes of Emotion and Cognitive Function and Brain Imaging in Uremic Patients Before and After Entering Dialysis</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beijing Friendship Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beijing Friendship Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      1. Observe the influence of entering hemodialysis treatment on the emotional and cognitive&#xD;
           functions of ESRD patients.&#xD;
&#xD;
        2. Observe the influence of entering hemodialysis treatment on the brain structure imaging&#xD;
           of ESRD patients.&#xD;
&#xD;
        3. Analyze and study the relevant clinical risk factors of the above-mentioned effects, and&#xD;
           find targets for therapeutic intervention.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Select uremic patients and maintenance hemodialysis patients admitted to the Central Dialysis&#xD;
      Room of Beijing Friendship Hospital, Capital Medical University from 2021, to collect and&#xD;
      sort out the demographic characteristics of the patients: gender, age, clinical&#xD;
      characteristics: primary disease, complications and Complications, body mass index (BMI),&#xD;
      residual renal function, etc., clinical examination indicators: hemoglobin, blood calcium,&#xD;
      blood phosphorus, blood PTH, blood albumin, URR, etc., hemodialysis treatment parameters:&#xD;
      dialysis mode, dialyzer model, vascular access , Blood flow, etc., record the patient's&#xD;
      emotional and cognitive function status, various clinical indicators and changes in the&#xD;
      patient's quality of life before and after the start of treatment, and use multimodal&#xD;
      magnetic resonance neuroimaging research sequences to analyze the changes in the patient's&#xD;
      brain structure and function.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2025</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Appears obvious emotional and cognitive decline, or abnormal head MRI</measure>
    <time_frame>2 years</time_frame>
    <description>Appears obvious emotional and cognitive decline, or abnormal head MRI</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Kidney Failure, Chronic</condition>
  <condition>Cognitive Dysfunction</condition>
  <condition>Magnetic Resonance Imaging</condition>
  <arm_group>
    <arm_group_label>Newly HD patients</arm_group_label>
    <description>Newly admitted patients with uremia who started hemodialysis treatment</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MHD patients</arm_group_label>
    <description>Maintenance hemodialysis patients</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>This is an observational study</intervention_name>
    <description>This is an observational study</description>
    <arm_group_label>MHD patients</arm_group_label>
    <arm_group_label>Newly HD patients</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Uremia patients undergoing hemodialysis treatment in the hemodialysis room of Beijing&#xD;
        Friendship Hospital&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients who are new to hemodialysis treatment, and those who are on regular&#xD;
             hemodialysis treatment for ≥6 months.&#xD;
&#xD;
          -  Age ≥ 18 years old.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  There was already a severe central nervous system disease before dialysis.&#xD;
&#xD;
          -  Hearing and visual impairment cannot communicate or cooperate.&#xD;
&#xD;
          -  Mental illness and incapacity.&#xD;
&#xD;
          -  The magnetic resonance examination could not be completed for various reasons.&#xD;
&#xD;
          -  Life expectancy with serious diseases is less than 6 months.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>WENHU LIU, doctor</last_name>
    <role>Study Director</role>
    <affiliation>Beijing Friendship Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>XU LIU, master</last_name>
    <phone>+86-010-63138579</phone>
    <email>liuxu_000@sina.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beijing Friendship Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100050</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>XU LIU, master</last_name>
      <phone>+861063138579</phone>
      <email>liuxu_000@sina.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>November 24, 2021</study_first_submitted>
  <study_first_submitted_qc>November 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 30, 2021</study_first_posted>
  <last_update_submitted>November 24, 2021</last_update_submitted>
  <last_update_submitted_qc>November 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 30, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
    <mesh_term>Kidney Failure, Chronic</mesh_term>
    <mesh_term>Cognitive Dysfunction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

